Vascular Biogenics - ADR Financials

$0.17

$-5.82 (-97.19%)

As on 16-Oct-2023 19:58EDT

Market cap

$12 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-31.59	-24.98	-23.38	-12.70	-15.68
Cash Flow from Investing Activities	--	--	-15.49	9.89	-6.10	24.73
Cash from Financing Activities	--	0.02	49.11	17.07	-0.76	13.67
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.16	-0.42	-0.41	-0.47	-0.55	-0.57
Cash EPS ($)	--	-0.40	-0.39	-0.44	-0.50	-0.54
Adjusted Book Value ($)	--	0.29	0.74	0.59	0.99	1.48
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.41	-0.36	-0.45	-0.35	-0.44
Free Cash Flow per Share ($)	--	-0.42	-0.38	-0.45	-0.35	-0.50

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-83.10	-65.26	-67.37	-42.67	-37.27
ROE (%)	-60.38	-86.34	-69.10	-72.89	-44.46	-37.54
ROA (%)	-29.94	-68.32	-53.98	-53.87	-36.18	-32.38
EBIT Margin (%)	-11,453.03	-4,992.86	-3,905.73	-2,655.42	-3,561.21	-3,604.27
Net Margin (%)	-2,118.86	-4,896.50	-3,738.02	-2,638.83	-3,517.79	-3,497.09
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3.85	-0.14	-0.17	0.64	-0.04	-0.96
EBIT Growth (%)	-90.19	-9.52	-22.52	-22.33	5.08	-94.08
Net Profit Growth (%)	64.20	-12.23	-17.99	-23.07	3.36	-101.80
EPS Growth (%)	65.85	-0.02	0.13	0.15	0.04	-0.68
Book Value Growth (%)	-44.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.29	-4.82	-4.05	-2.19	-1.70
Price / Book Value	0.35	0.41	2.65	3.19	1.21	0.66
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.48	0.35	-2.94	-3.09	-0.56	0.75
Close Price ($)	8.05	4.20	68.95	66.15	42.00	33.95
High Price ($)	77.00	77.00	110.95	72.10	66.50	306.25
Low Price ($)	3.53	3.53	57.75	31.50	32.55	21.00
Market Cap ($ Cr)	12.11	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.03	0.05	0.08	0.08	0.01
Short term debt to equity ratio	--	0.03	0.01	0.02	0.02	0.01
Current Ratio	4.63	3.29	5.53	4.29	4.33	10.83
Quick Ratio	4.63	3.10	5.57	4.11	4.26	--
Interest Coverage	-198.44	-386.51	-681.73	-233.17	-63.94	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	15.50	60.55	34.92	111.92	89.06
Asset Turnover	0.01	0.01	0.01	0.02	0.01	0.01
Receivable days	--	157.37	187.14	188.37	373.70	1,207.51
Inventory Days	--	1,490.85	450.81	912.20	1,348.96	438.30
Payable days	--	9,024.13	3,147.65	2,452.00	5,067.56	3,303.57
Cash Conversion Cycle	--	-7,375.91	-2,509.70	-1,351.43	-3,344.90	-1,657.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.